It-chem
KOSDAQTotal Valuation
It-chem carries a market capitalization of 262.39B, placing it among publicly traded companies globally. Its enterprise value stands at 343.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 262.39B |
| Enterprise Value | 343.31B |
Valuation Ratios
The price-to-sales ratio is 4.87, and the price-to-book ratio stands at -6.40.
| PE Ratio | N/A |
| PS Ratio | 4.87 |
| PB Ratio | -6.40 |
| P/TBV Ratio | 4.67 |
| P/FCF Ratio | 8.14 |
| P/OCF Ratio | -32.58 |
Enterprise Valuation
On an enterprise value basis, It-chem trades at an EV/EBITDA multiple of 434.02 and an EV/FCF ratio of 9.01. The EV/Sales ratio of 5.94 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 434.02 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.94 |
| EV / EBITDA | 434.02 |
| EV / EBIT | 434.02 |
| EV / FCF | 9.01 |
Financial Position
It-chem maintains a current ratio of 0.80, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 175.50, indicating elevated leverage, while an interest coverage ratio of -0.93 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.80 |
| Quick Ratio | 0.42 |
| Debt / Equity | 175.50 |
| Debt / EBITDA | -30.54 |
| Interest Coverage | -0.93 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -10.04 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.43 |
Taxes
| Income Tax | -2.20B |
| Effective Tax Rate | N/A |
Stock Price Statistics
It-chem's stock has declined approximately -32.36715% over the past 52 weeks. The 50-day moving average sits at 33,005.00, while the 200-day moving average is 31,203.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | -32.36715% |
| 50-Day Moving Average | 33,005.00 |
| 200-Day Moving Average | 31,203.12 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, It-chem generated 57.80B in revenue and converted that into -18.00B in net income, yielding earnings per share of -1,541.36. EBITDA reached -3.51B, while operating income came in at -3.51B.
| Revenue | 57.80B |
| Gross Profit | 8.82B |
| Operating Income | -3.51B |
| Pretax Income | -20.21B |
| Net Income | -18.00B |
| EBITDA | -3.51B |
| EBIT | -3.51B |
| Earnings Per Share (EPS) | -1,541.36 |
Balance Sheet
It-chem holds 45.46B in cash and equivalents against 107.18B in total debt, resulting in a net debt position of 87.38B. Total book value stands at -43.97B, with working capital of -21.63B providing operational flexibility.
| Cash & Cash Equivalents | 45.46B |
| Total Debt | 107.18B |
| Net Debt | 87.38B |
| Equity (Book Value) | -43.97B |
| Book Value Per Share | -3,778.80 |
| Working Capital | -21.63B |
Cash Flow
It-chem produced -8.64B in operating cash flow over the past twelve months. After subtracting -43.36B in capital expenditures, free cash flow totaled -52.00B - equivalent to -4,468.71 per share.
| Operating Cash Flow | -8.64B |
| Capital Expenditures | -43.36B |
| Free Cash Flow | -52.00B |
| FCF Per Share | -4,468.71 |
Margins
It-chem operates with a gross margin of 15.27, reflecting its pricing power and cost economics. The operating margin of -6.07 and net profit margin of -31.15 provide insight into operational efficiency.
| Gross Margin | 15.27 |
| Operating Margin | -6.07 |
| Pretax Margin | -34.96 |
| Profit Margin | -31.15 |
| EBITDA Margin | -6.07 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -36.13 |
| FCF Yield | 12.28 |
Scores
It-chem posts an Altman Z-Score of 0.79, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.79 |